A hybrid Fc-fused human growth hormone, GX-H9, shows a potential for semi-monthly administration in both adult and pediatric growth hormone deficiencies.

H. Michael Keyoung

Presentation information

APPES/JSPE Joint Session(English)

APPES/JSPE Joint Session(English) » Oral

Oral 4: Growth

Sat. Nov 19, 2016 10:45 AM - 11:45 AM Room 1 (Hall C)

Moderator: Junko Ito (The Head of Department of Pediatrics, Toranomon Hospital Tokyo), Melinda Atienza (Department of Pediatrics Faculty of Medicine and Surgery University of Santo Tomas Manila)

11:35 AM - 11:45 AM

[O4-6] A hybrid Fc-fused human growth hormone, GX-H9, shows a potential for semi-monthly administration in both adult and pediatric growth hormone deficiencies.

^○H. Michael Keyoung¹, Aryaev Mykola², Eun Jig Lee³, Jochen Schopohl⁴, Tae Kyung Kim¹, Young-Joo Ahn⁵, Jung-Won Woo¹, Woo Ick Jang⁵, Young-Chul Sung¹ (1.Genexine, Inc., 2.Department of pathology of the newborns and premature infants, Municipal Institution, 3.Department of Internal Medicine IV, Ludwig-Maximilians University Munich, 4.Endocrinology/ Internal Medicine, Yonsei University College of Medicine, 5.Handok, Inc.)

The password will be announced in the abstract book.

Presentation information

Oral 4: Growth

[O4-6] A hybrid Fc-fused human growth hormone, GX-H9, shows a potential for semi-monthly administration in both adult and pediatric growth hormone deficiencies.

Password